Skip to content

AIM round-up: St James House, I-Nexus Global, Yourgene Health

AIM round-up: St James House, I-Nexus Global, Yourgene Health

Despite spending the bulk of the session in positive territory, London’s AIM Index slipped back in line with the US open, reaching the bell just over one and a half points lower at 1252.70

  • St James House +40%
  • I-Nexus Global +38%
  • Yourgene Health +10%
  • Pantheon Resources -43%
  • Agriterra -18%

St James House [LON:SJH] was the day’s biggest riser, coming close to adding 100% at one point off the back a well received statement ahead of the company’s AGM. That was pertaining to a partnership which has effected a change management process starting tomorrow. Some of the upside ebbed away however, but the stock still closed up 40% on the day.


I-Nexus Global LON:INX also fared well, adding 38% by the bell and extending the rally which kicked off before the weekend break. Perhaps tellingly, there was no notification from the company this morning regarding the abnormal share price movement, heightening suspicion that contract news may be afoot. Long term investors who have seen the stock languish for the last year will be rightly pleased.

Pantheon Resources LON:PANR was by the bell the day’s biggest casualty, sitting some 43% adrift. An operational update released this morning, whilst containing some encouraging news, concluded with the CEO admitting disappointment that they hadn’t yet managed to deliver the proof of high flow rates they had been hoping for. The news has reversed more than six months of share price growth for the company and further testing progress will apparently have to wait until next winter.

Minnow Agriterra LON:AGTA made for the day’s second biggest faller, finishing some 18% lower although with a sub £1m market cap, a hulking spread of almost 50% being quoted and very limited trade, being seen, it appears here as a technical note and not much else.

A notable mention to Yourgene Health LON:YGEN, which we flagged in our morning report following news it had made it to the tender round of a government COVID programme, bidding for a slice of £3bn worth of work. A mid-session update added to the good news, with word that the company had also made it into another bidding lot which could prove even more lucrative, although as was stressed in the earlier statement, there are no guarantees of contracts being won. Shares reached the bell some 10% higher.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top